Actos Bladder Cancer Lawsuit Filed in NevadaJanuary 23, 2015 — The family of a man from Henderson, Nevada has filed a lawsuit against Takeda Pharmaceutical Co. for failing to warn that the diabetes drug Actos may increase the risk of diabetes.

The plaintiff, Moshe Bitton, was diagnosed with bladder cancer in August 2011 after taking Actos for about four years. He died of bladder cancer on October 23, 2013, according to the Las Vegas Review-Journal.

The lawsuit was filed this week in the U.S. District Court for Nevada, which is located in Las Vegas.

As of January 15, Takeda was facing 3,972 lawsuits involving Actos, with less than 200 dismissed or resolved. The last trial in Las Vegas was in June 2014, and it ended with a defense verdict in favor of Takeda and against two women who developed bladder cancer.

However, Takeda has lost some trials, including a record-setting $9 billion jury verdict. Last October, a jury in Philadelphia awarded $2 million to a woman who developed bladder cancer. That same month, a federal judge slashed 99% off the $9 billion verdict, awarding the plaintiff just $37 million due to state laws capping punitive damages.

Problems for Takeda began in June 2011, when the FDA issued a Safety Communication to warn that a five-year study found that patients who used high doses of Actos for at least one year were 40% more likely to develop bladder cancer. The risk of bladder cancer increased with dosage and duration of treatment.

Need a Texas Actos Lawyer?

Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged.

Collen’s amazing success in the courtroom and well known dedication to his clients has earned him the recognition of his peers as one of The Top Trial Lawyers in Texas.”

The Clark Firm has assembled a team of trial lawyers with more than 100 years experience, participation in over 600 jury trials and $260 million in verdicts and/or settlements. Please use the form below to contact our Texas Actos lawyers for a free lawsuit review.